Jonathan Lanfear - 27 Oct 2023 Form 4 Insider Report for Molecular Templates, Inc.

Reporting relationship: Director
Issuer ticker: N/A
Reported as of: 27 Oct 2023
Net transaction value: $0
SEC form: 4
Accepted by SEC: 31 Oct 2023, 18:46:09 UTC
Prior SEC filing: 06 Jun 2022
Source filing: View source filing
Reporting owner signature: /s/ Jonathan Lanfear

Key filing fact

Jonathan Lanfear filed Form 4 for Molecular Templates, Inc. on 31 Oct 2023.

Key facts

This page summarizes Jonathan Lanfear's Form 4 filing for Molecular Templates, Inc..
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 31 Oct 2023, 18:46.

Change

Previous filing in this sequence was filed on 06 Jun 2022.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

MTEM transaction Derivative

Stock Option (right to buy)

Award

Transaction value: $0
Shares: +1,000
Change %
Price: $0.000000
Shares after: 1,000
Date: 27 Oct 2023
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 1,000
Exercise price: $6.06
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

The figures reflected herein have been adjusted to take into account a 1 for 15 reverse split of the Company's common stock that was effected on August 11, 2023.

Footnote F2

The shares of common stock exercisable pursuant to the option will vest in full upon completion of continuous service for the Issuer on the first anniversary of the vesting commencement date of October 27, 2023.